These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4087 related articles for article (PubMed ID: 34635121)

  • 1. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer associated-fibroblast-derived exosomes in cancer progression.
    Li C; Teixeira AF; Zhu HJ; Ten Dijke P
    Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
    Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
    Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.
    Khalaf K; Hana D; Chou JT; Singh C; Mackiewicz A; Kaczmarek M
    Front Immunol; 2021; 12():656364. PubMed ID: 34122412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer associated fibroblasts: phenotypic and functional heterogeneity.
    Patel AK; Singh S
    Front Biosci (Landmark Ed); 2020 Mar; 25(5):961-978. PubMed ID: 32114420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapy.
    Jia S; Bode AM; Chen X; Luo X
    Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189166. PubMed ID: 39111710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential.
    Milosevic V; Östman A
    Ups J Med Sci; 2024; 129():. PubMed ID: 38863724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy.
    Allam A; Yakou M; Pang L; Ernst M; Huynh J
    Front Immunol; 2021; 12():767939. PubMed ID: 34858425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment.
    Laha D; Grant R; Mishra P; Nilubol N
    Front Immunol; 2021; 12():656908. PubMed ID: 33986746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives.
    Fang Z; Xu J; Zhang B; Wang W; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
    J Hematol Oncol; 2020 Nov; 13(1):154. PubMed ID: 33213510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model.
    Nascimento C; Ferreira F
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188587. PubMed ID: 34237352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment.
    Monteran L; Erez N
    Front Immunol; 2019; 10():1835. PubMed ID: 31428105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.
    Akkız H
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.
    Soongsathitanon J; Jamjuntra P; Sumransub N; Yangngam S; De la Fuente M; Landskron G; Thuwajit P; Hermoso MA; Thuwajit C
    J Immunol Res; 2021; 2021():8840066. PubMed ID: 34337083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment.
    Liu K; Huang A; Nie J; Tan J; Xing S; Qu Y; Jiang K
    Front Immunol; 2021; 12():683332. PubMed ID: 34093586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A framework for advancing our understanding of cancer-associated fibroblasts.
    Sahai E; Astsaturov I; Cukierman E; DeNardo DG; Egeblad M; Evans RM; Fearon D; Greten FR; Hingorani SR; Hunter T; Hynes RO; Jain RK; Janowitz T; Jorgensen C; Kimmelman AC; Kolonin MG; Maki RG; Powers RS; Puré E; Ramirez DC; Scherz-Shouval R; Sherman MH; Stewart S; Tlsty TD; Tuveson DA; Watt FM; Weaver V; Weeraratna AT; Werb Z
    Nat Rev Cancer; 2020 Mar; 20(3):174-186. PubMed ID: 31980749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells.
    Sazeides C; Le A
    Adv Exp Med Biol; 2018; 1063():149-165. PubMed ID: 29946782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 205.